357 related articles for article (PubMed ID: 22939886)
1. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
[TBL] [Abstract][Full Text] [Related]
2. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
3. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice.
Anisiewicz A; Kowalski K; Banach J; Łabędź N; Stachowicz-Suhs M; Piotrowska A; Milczarek M; Kłopotowska D; Dzięgiel P; Wietrzyk J
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33172201
[TBL] [Abstract][Full Text] [Related]
5. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and breast cancer: insights from animal models.
Welsh J
Am J Clin Nutr; 2004 Dec; 80(6 Suppl):1721S-4S. PubMed ID: 15585794
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.
Swami S; Krishnan AV; Williams J; Aggarwal A; Albertelli MA; Horst RL; Feldman BJ; Feldman D
Endocr Relat Cancer; 2016 Apr; 23(4):251-64. PubMed ID: 26817629
[TBL] [Abstract][Full Text] [Related]
9. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.
Kemmis CM; Welsh J
J Cell Biochem; 2008 Nov; 105(4):980-8. PubMed ID: 18767073
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D.
Jeong Y; Swami S; Krishnan AV; Williams JD; Martin S; Horst RL; Albertelli MA; Feldman BJ; Feldman D; Diehn M
Mol Cancer Ther; 2015 Aug; 14(8):1951-61. PubMed ID: 25934710
[TBL] [Abstract][Full Text] [Related]
11. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.
Swami S; Krishnan AV; Wang JY; Jensen K; Peng L; Albertelli MA; Feldman D
Horm Cancer; 2011 Jun; 2(3):190-202. PubMed ID: 21686077
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D metabolism and action in the prostate: implications for health and disease.
Swami S; Krishnan AV; Feldman D
Mol Cell Endocrinol; 2011 Dec; 347(1-2):61-9. PubMed ID: 21664249
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
15. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
16. Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.
García-Quiroz J; García-Becerra R; Lara-Sotelo G; Avila E; López S; Santos-Martínez N; Halhali A; Ordaz-Rosado D; Barrera D; Olmos-Ortiz A; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2017 Oct; 173():148-156. PubMed ID: 27639478
[TBL] [Abstract][Full Text] [Related]
17. Tumoral Vitamin D Synthesis by CYP27B1 1-α-Hydroxylase Delays Mammary Tumor Progression in the PyMT-MMTV Mouse Model and Its Action Involves NF-κB Modulation.
Li J; Luco AL; Ochietti B; Fadhil I; Camirand A; Reinhardt TA; St-Arnaud R; Muller W; Kremer R
Endocrinology; 2016 Jun; 157(6):2204-16. PubMed ID: 27119753
[TBL] [Abstract][Full Text] [Related]
18. Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.
Kállay E; Bises G; Bajna E; Bieglmayer C; Gerdenitsch W; Steffan I; Kato S; Armbrecht HJ; Cross HS
Carcinogenesis; 2005 Sep; 26(9):1581-9. PubMed ID: 15905206
[TBL] [Abstract][Full Text] [Related]
19. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation.
Liu N; Nguyen L; Chun RF; Lagishetty V; Ren S; Wu S; Hollis B; DeLuca HF; Adams JS; Hewison M
Endocrinology; 2008 Oct; 149(10):4799-808. PubMed ID: 18535110
[TBL] [Abstract][Full Text] [Related]
20. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
